Meimei Wan
- Molecular Biology
- Cancer Research top 10%
- Biomedical Engineering
- Oncology
- Pulmonary and Respiratory Medicine
- Co-authors
- Guangchao SuiPaul D. CaoWeiwei HuangMing LeiAnthony AtalaZhiyong DengJianfeng XuScott D. Cramer
- Topics
- Liver physiology and pathology (3 papers)Epigenetics and DNA Methylation (3 papers)MicroRNA in disease regulation (3 papers)
- Partner nations
- United StatesChinaNepal
In The Last Decade
Meimei Wan
20 papers receiving 906 citations
Peers
Comparison fields: 5 of 76
- Molecular Biology 659
- Cancer Research 306
- Biomedical Engineering 154
- Oncology 117
- Pulmonary and Respiratory Medicine 68
Countries citing papers authored by Meimei Wan
This map shows the geographic impact of Meimei Wan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Meimei Wan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Meimei Wan more than expected).
Fields of papers citing papers by Meimei Wan
This network shows the impact of papers produced by Meimei Wan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Meimei Wan. The network helps show where Meimei Wan may publish in the future.
Co-authorship network of co-authors of Meimei Wan
This figure shows the co-authorship network connecting the top 25 collaborators of Meimei Wan. A scholar is included among the top collaborators of Meimei Wan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Meimei Wan. Meimei Wan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 1 | |
| 2 | 0 | |
| 3 | 20 | |
| 4 | 3 | |
| 5 | 20 | |
| 6 | 2 | |
| 7 | 21 | |
| 8 | 144 | |
| 9 | 51 | |
| 10 | 22 | |
| 11 | 28 | |
| 12 | 37 | |
| 13 | 51 | |
| 14 | 2 | |
| 15 | 77 | |
| 16 | 24 | |
| 17 | 85 | |
| 18 | 203 | |
| 19 | 23 | |
| 20 | 70 |
About Meimei Wan
Meimei Wan is a scholar working on Hepatology, Cancer Research and Molecular Biology, having authored 21 papers that have together received 915 indexed citations. Recurring topics across this work include Liver physiology and pathology (3 papers), Epigenetics and DNA Methylation (3 papers) and MicroRNA in disease regulation (3 papers). The work is most often cited by research in Cancer Research (306 citations), Molecular Biology (659 citations) and Hepatology (46 citations). Meimei Wan has collaborated with scholars based in United States, China and Nepal. Frequent co-authors include Guangchao Sui, Paul D. Cao, Weiwei Huang, Ming Lei, Anthony Atala, Zhiyong Deng, Zhiyong Deng, Jianfeng Xu, Scott D. Cramer and Colin E. Bishop. Their work appears in journals such as Nucleic Acids Research, Blood and The Journal of Immunology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.